BostonGene

OverviewSuggest Edit

BostonGene operates as a biomedical software company providing solutions for fighting cancer. It offers a cloud platform which performs analytics to aid clinicians in their evaluation of viable treatment options for each patient's individual genetics, tumor and tumor microenvironment, clinical characteristics and disease profile. The Company's mission is to enable physicians to provide every patient with the highest probability of survival through optimal cancer treatments using personalized therapies. 

TypePrivate
Founded2015
HQWaltham, US
Websitebostongene.com
Employee Ratings3.6

Latest Updates

Employees (est.) (Oct 2020)98(+7%)
Cybersecurity ratingAMore

Key People/Management at BostonGene

Andrew Feinberg

Andrew Feinberg

President, CEO

BostonGene Office Locations

BostonGene has an office in Waltham
Waltham, US (HQ)
95 Sawyer Rd #600
Show all (1)

BostonGene Financials and Metrics

Summary Metrics

Founding Date

2015

BostonGene total Funding

$50 m

BostonGene latest funding size

$50 m

Time since last funding

a year ago

BostonGene investors

BostonGene's latest funding round in April 2019 was reported to be $50 m. In total, BostonGene has raised $50 m
Show all financial metrics

BostonGene Cybersecurity Score

Cybersecurity ratingPremium dataset

A

90/100

SecurityScorecard logo

BostonGene Online and Social Media Presence

Embed Graph

BostonGene Blogs

BostonGene Announces Cancer Research Collaboration with Washington University in St. Louis

Integration of Genomic, Transcriptomic, Proteomic and Imaging Analysis aimed at Understanding Cancer Progression and Tumor Microenvironment Involvement WALTHAM, MA – October 8, 2019 – BostonGene Corporation (BostonGene), a Boston, Mass-based biomedical software company, today announced a master agre…

BostonGene Announces Agreement with The University of Texas MD Anderson Cancer Center

Multiple Research Projects Analyze Genomic Data Sets to Understand Disease Progression and Therapeutic Resistance WALTHAM, MA – September 10, 2019 – BostonGene Corporation (BostonGene), a biomedical software company, today announced an agreement with The University of Texas MD Anderson Cancer Center…

BostonGene Partners With NIH on Clonal Evolution Study

BostonGene today announced a partnership with the National Institutes of Health to offer molecular profiling and therapy recommendations in a cancer study. The post BostonGene Partners With NIH on Clonal Evolution Study appeared first on BostonGene.

BostonGene Announces Partnership with National Institutes of Health

Precision Medicine Studies Underway to Enable Dynamic Monitoring of Disease Progression and Response to Treatment WALTHAM, MA – July 23, 2019 – BostonGene Corporation (BostonGene), a biomedical software company, today announced its partnership with the National Institutes of Health (NIH) including t…
Show more

BostonGene Frequently Asked Questions

  • When was BostonGene founded?

    BostonGene was founded in 2015.

  • Who are BostonGene key executives?

    BostonGene's key executives are Andrew Feinberg.

  • How many employees does BostonGene have?

    BostonGene has 98 employees.

  • Who are BostonGene competitors?

    Competitors of BostonGene include Fauna Bio, Step Pharma and Lacerta Therapeutics.

  • Where is BostonGene headquarters?

    BostonGene headquarters is located at 95 Sawyer Rd #600, Waltham.

  • Where are BostonGene offices?

    BostonGene has an office in Waltham.

  • How many offices does BostonGene have?

    BostonGene has 1 office.